Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lila T. Yokanovich
Observed names:
LT Yokanovich,
Lila T Yokanovich,
Lila Yokanovich
Observed institution:
Mayo Clinic
ORCID:
0000-0002-3823-4051
Observed ORCID:
0000-0002-3823-4051
OpenAlex ID:
A5002497763
Microglia and Perivascular Macrophages Act as Antigen Presenting Cells to Promote CD8 T Cell Infiltration of the Brain
2021
·
Emma N. Goddery
, Cori E Fain
, et al.
·
Frontiers in Immunology
·
120
Brain cancer induces systemic immunosuppression through release of non-steroid soluble mediators
2020
·
Katayoun Ayasoufi
, Christian K Pfaller
, et al.
·
Brain
·
99
PDF
Brain Resident Memory T Cells Rapidly Expand and Initiate Neuroinflammatory Responses Following CNS Injury and Viral Infection
2022
·
Katayoun Ayasoufi
, Delaney M. Wolf
, et al.
·
SSRN Electronic Journal
·
54
Regulation of oral antigen delivery early in life: Implications for oral tolerance and food allergy
2021
·
Lila T. Yokanovich
, Rodney D. Newberry
, et al.
·
Clinical & Experimental Allergy
·
34
Conditional Silencing of H-2Db Class I Molecule Expression Modulates the Protective and Pathogenic Kinetics of Virus-Antigen–Specific CD8 T Cell Responses during Theiler's Virus Infection
2020
·
Zachariah P Tritz
, Robin C Orozco
, et al.
·
The Journal of Immunology
·
15
PDF
Anti–PD-1 and Extended Half-life IL2 Synergize for Treatment of Murine Glioblastoma Independent of Host MHC Class I Expression
2023
·
Zachariah P. Tritz
, Katayoun Ayasoufi
, et al.
·
Cancer Immunology Research
·
7
PDF
Combination immunotherapy of αPD-1 and extended half-life IL-2 clears established GL261 gliomas in an MHC class I independent fashion
2020
·
Zachariah Peter Tritz
, Kathy Ayasoufi
, et al.
·
The Journal of Immunology
·
3
Immunopathology and Meningitis During Late-Onset Gut-Originating Neonatal Sepsis
2021
·
Lila T Yokanovich
, Kara Greenfield
, et al.
·
The Journal of Immunology
·
1
Scidot-34. Brain Injury Signals Systemic Immunosuppression Through Thymic Involution
2019
·
Katayoun Ayasoufi
, Christian K Pfaller
, et al.
·
Neuro-Oncology
·
1
PDF
Rapid activation of brain resident memory T cells following neurological insults
2019
·
Katayoun Ayasoufi
, Shelby Namen
, et al.
·
The Journal of Immunology
·
1
Supplementary Figure 1 from Anti–PD-1 and Extended Half-life IL2 Synergize for Treatment of Murine Glioblastoma Independent of Host MHC Class I Expression
2025
·
Zachariah P. Tritz
, Katayoun Ayasoufi
, et al.
Supplementary Figure 1 from Anti-PD-1 and extended half-life-IL-2 synergize for treatment of murine glioblastoma independent of host MHC Class I expression
2024
·
Zachariah P. Tritz
, Katayoun Ayasoufi
, et al.
Supplementary Figure 1 from Anti-PD-1 and extended half-life-IL-2 synergize for treatment of murine glioblastoma independent of host MHC Class I expression
2024
·
Zachariah P. Tritz
, Katayoun Ayasoufi
, et al.
Developing thymocytes cue in unique subsets of neurons to support optimal thymic architecture
2024
·
Alexandra Hoyt-Miggelbrink
, Christian Pfaller
, et al.
·
The Journal of Immunology
Exth-77. Extended Half-life Il-2 Synergizes With Α-pd-1 for Treatment of Preclinical Murine Glioblastoma Models
2023
·
Carley Owens
, Zachariah Tritz
, et al.
·
Neuro-Oncology
PDF
Supplementary Figure 1 from Anti–PD-1 and Extended Half-life IL2 Synergize for Treatment of Murine Glioblastoma Independent of Host MHC Class I Expression
2023
·
Zachariah P. Tritz
, Katayoun Ayasoufi
, et al.
Data from Anti–PD-1 and Extended Half-life IL2 Synergize for Treatment of Murine Glioblastoma Independent of Host MHC Class I Expression
2023
·
Zachariah P. Tritz
, Katayoun Ayasoufi
, et al.
Supplementary Figure 1 from Anti–PD-1 and Extended Half-life IL2 Synergize for Treatment of Murine Glioblastoma Independent of Host MHC Class I Expression
2023
·
Zachariah P. Tritz
, Katayoun Ayasoufi
, et al.
Data from Anti–PD-1 and Extended Half-life IL2 Synergize for Treatment of Murine Glioblastoma Independent of Host MHC Class I Expression
2023
·
Zachariah P. Tritz
, Katayoun Ayasoufi
, et al.
Data from Anti–PD-1 and Extended Half-life IL2 Synergize for Treatment of Murine Glioblastoma Independent of Host MHC Class I Expression
2023
·
Zachariah P. Tritz
, Katayoun Ayasoufi
, et al.
Supplementary Figure 1 from Anti–PD-1 and Extended Half-life IL2 Synergize for Treatment of Murine Glioblastoma Independent of Host MHC Class I Expression
2023
·
Zachariah P. Tritz
, Katayoun Ayasoufi
, et al.
Supplementary Figure 1 from Anti–PD-1 and Extended Half-life IL2 Synergize for Treatment of Murine Glioblastoma Independent of Host MHC Class I Expression
2023
·
Zachariah P. Tritz
, Katayoun Ayasoufi
, et al.
Age-Dependent Responses of γδ+ T cells During Bloodstream Infection in Early Life
2022
·
Lila T Yokanovich
, Kara Greenfield
, et al.
·
The Journal of Immunology
Combination of αPD-1 and extended half-life IL-2 is effective against the GL261 glioma and uniquely reverses GBM-associated immunosuppression
2022
·
Zachariah Peter Tritz
, Katayoun Ayasoufi
, et al.
·
The Journal of Immunology
Exth-66. Enhancement of Anti-pd-1 Therapy With Extended Half-life Il-2 Is Independent of Mhc Class I Restricted Antigen Recognition for Treatment of Experimental Glioma
2021
·
Zachariah Tritz
, Katayoun Ayasoufi
, et al.
·
Neuro-Oncology
PDF
Show more works
View as search
Works count:
33
Citation count:
335
H-index:
6
I10-index:
5
Year
Topic
Type
